A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1093/jac/dkr377
Authors: K. W. Garey, S. S. Ghantoji, D. N. Shah, M. Habib, V. Arora, Z.-D. Jiang, H. L. DuPont
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2114314510
